Hearst Health

Greg Dorn is a senior vice president of Hearst and the president and group head of Hearst Health, overseeing Hearst’s healthcare businesses in the U.S. and globally, including FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK. He also serves as a director of M2Gen and is a member of the Hearst board of directors. 

For more than two decades, Dorn has been focused on raising the standard of excellence for patient care across the healthcare spectrum, through clinically rigorous guidance delivered by efficient, scalable technology. He is the co-inventor of two patented healthcare software technologies that continue to be used in health systems across the U.S. His expertise is in developing and commercializing inventive and disruptive solutions that improve care quality and efficiency.

Dorn has held a variety of leadership positions across Hearst, including chief operating officer of Zynx Health and president of FDB. In 2013 he was appointed a vice president of Hearst to lead its growing portfolio of healthcare companies. He became president of Hearst Health in 2014. The mission of Hearst Health is to guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions.

Dorn received his medical doctorate from the Columbia University College of Physicians and Surgeons and his bachelor’s degree from the Columbia University School of Engineering. He performed his clinical training at UCLA, where he also obtained his master’s degree in health services management.

Chuck Tuchinda is the executive vice president and deputy group head of Hearst Health, providing senior leadership for Hearst’s healthcare businesses in the U.S. and globally, including FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK. He also serves as executive chairman of FDB, president of Zynx Health, an adviser to M2Gen and vice president of Hearst.

The mission of Hearst Health is to guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions.

From the outset of his career, Tuchinda has invented and commercialized solutions that leverage modern technology to improve clinical decision-making. His expertise is in developing scalable and sustainable business models for novel technology-enabled clinical knowledge.

Tuchinda became president of FDB in 2014, leading the company in double-digit growth and expanding its business into adjacent markets. He first joined Hearst in 2010 as the chief innovation officer for healthcare, after holding a variety of executive roles at Eclypsis (now Allscripts) and leading several successful entrepreneurial endeavors.

A board-certified internal medicine physician, Tuchinda completed both his medical doctorate and residency training at Johns Hopkins. He received a master’s degree in business administration from Harvard Business School and a biomedical engineering degree from Harvard College.

Denielle deWynter is the senior vice president and chief financial officer of Hearst Health and is responsible for all aspects of the group’s financial strategies, processes and operations in the U.S. and globally. Hearst Health includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK. Hearst also holds a minority interest in M2Gen.

The mission of Hearst Health is to guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions.

DeWynter’s 20 years in global finance have been characterized by delivering global growth and performance across rapidly expanding businesses through strong relationship building and partnerships. Her expertise spans financial and operational transformation, financial planning and performance improvement.

In 2015, deWynter joined Hearst as a vice president of finance for its business media holdings and was quickly elevated to chief financial officer. She is a director of MHK and serves on the advisory board for HearstLab. In the decade preceding her Hearst appointment, deWynter held several leadership positions at S&P Global in global finance operations, global risk assessment, international reporting, financial operations and internal controls. Previously, she held positions at HSBC and Deloitte in London, Düsseldorf and Vancouver.

DeWynter is a member of the Canadian and British Columbia Institute of Chartered Accountants and received a bachelor’s degree in accounting from Simon Fraser University in Canada.

Jeff Rose is the senior vice president of clinical strategy for Hearst Health, leading care guidance initiatives that reach across FDB, Zynx Health, MCG, Homecare Homebase and MHK. He is a key adviser to M2Gen, a precision medicine and oncology genomics company of which Hearst owns a minority stake. In addition, Rose leads the Hearst Health government policy council.

The mission of Hearst Health is to guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions.

Rose is a nationally recognized informaticist and fellowship-trained physician with proven expertise in the development, implementation and use of health information technology across the industry and in clinical practice. He has extensive experience leading major initiatives ranging from clinical excellence and decision support to payer and provider collaboration in existing and emerging industry markets. He has twice been named one of Modern Healthcare’s top 25 clinical informaticists.

Throughout his career, Rose’s passion has centered on systems for the improvement of care quality for patients in every setting where care is delivered. Prior to joining Hearst in 2014, Rose held various leadership roles in clinical informatics, including vice president of clinical excellence in informatics at Ascension, chief medical officer of Cerner Corporation, chief medical officer of Health Language Inc. and director of clinical information systems for the Rocky Mountain division of Kaiser Permanente. He most recently served as the chief medical information officer at TriZetto Corporation, where his focus was on revenue cycle management, payer claims software systems and evolving payment models in the post-ACA healthcare world.

His humanitarian work in healthcare includes the African Health and Hospital Foundation, which he and his wife, Jill, founded in 2007 to provide medical aid and supplies for impoverished communities in East Africa.

Rose completed his medical doctorate and fellowship training at the University of Colorado Health Science Center. He is a board-certified interventional radiologist and has 15 years of clinical practice and physician group leadership experience in addition to his informatics work. He is an instructor for the American Association for Physician Leadership, an author of multiple pieces, including the books Invasive Radiology: Risks and Patient Care and Medicine and the Information Age.

Barin Rovzar is senior vice president and head of mergers and acquisitions for Hearst Health. She previously served as vice president of finance for Hearst, where she was responsible for corporate development efforts principally aligned with the company’s business media interests. Prior to that, she was an executive director within Hearst’s technology group focused on innovation and emerging technologies.

Rovzar joined Hearst from McKinsey & Company where she served healthcare and media clients as a consultant with the firm’s New York office. She began her career at the Advisory Board Company, a syndicated research and technology firm focused on healthcare organizations, where she held several roles in the company’s commercial functions.

Rovzar completed her undergraduate studies at Cornell University and obtained a master’s degree from the Kellogg School of Management at Northwestern University.